SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Clinical trial NCT06199882 · SUSPENDED

Trial details

NCT number: NCT06199882
Sponsor: Zhejiang Cancer Hospital
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Carcinoma

Start date: 2024-02-01
Primary completion: 2025-06-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.